Search research articles
Contact Us
Filters
Showing results (111-120 of 141) with videos related to
Page
of 15
Sort By:
European Urology Oncology
|
August 28, 2023
Sexual Structure Sparing for Prostate Cancer Radiotherapy: A Systematic Review
Jennifer Le Guevelou, Paul Sargos, Ludovic Ferretti, et al.
Frontiers in Medicine
|
July 28, 2020
Integration of 18-FDG PET/CT in the Initial Work-Up to Stage Head and Neck Cancer: Prognostic Significance and Impact on Therapeutic Decision Making
Jean-Christophe Leclere, Olivier Delcroix, Jean Rousset, et al.
Pathology
|
September 14, 2021
Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing
Amélie Bourhis, Charline Caumont, Isabelle Quintin-Roué, et al.
Scientific Reports
|
April 8, 2023
Prognostic value of pre-therapeutic FDG-PET radiomic analysis in gastro-esophageal junction cancer
Karim Amrane, Philippe Thuillier, David Bourhis, et al.
Cancers
|
April 2, 2020
External Validation of an MRI-Derived Radiomics Model to Predict Biochemical Recurrence after Surgery for High-Risk Prostate Cancer
Vincent Bourbonne, Georges Fournier, Martin Vallières, et al.
Rare Tumors
|
October 3, 2014
History of the rare cancer network and past research
René-Olivier Mirimanoff, Mahmut Ozsahin, Juliette Thariat, et al.
Cancer Medicine
|
February 6, 2020
First-line pembrolizumab for non-small cell lung cancer patients with PD-L1 ≥50% in a multicenter real-life cohort: The PEMBREIZH study
Karim Amrane, Margaux Geier, Romain Corre, et al.
Cancers
|
March 29, 2023
A Feasibility Study of Functional Lung Volume Preservation during Stereotactic Body Radiotherapy Guided by Gallium-<sup>68</sup> Perfusion PET/CT
François Lucia, Mohamed Hamya, Fanny Pinot, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 15, 2012
Clinical impact of 18F-choline PET/CT in patients with recurrent prostate cancer
Jan D Soyka, Marco A Muster, Daniel T Schmid, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 11, 2024
Diagnostic Performance of <sup>18</sup>F-FDG PET/CT According to Delay After Treatment to Detect Subclinical Recurrence of Head and Neck Squamous Cell Carcinoma
Camille Clement, Jean-Christophe Leclère, Clémentine Maheo, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 141) with videos related to
Sort By:
Page
of 15
European Urology Oncology
|
August 28, 2023
Sexual Structure Sparing for Prostate Cancer Radiotherapy: A Systematic Review
Jennifer Le Guevelou, Paul Sargos, Ludovic Ferretti, et al.
Frontiers in Medicine
|
July 28, 2020
Integration of 18-FDG PET/CT in the Initial Work-Up to Stage Head and Neck Cancer: Prognostic Significance and Impact on Therapeutic Decision Making
Jean-Christophe Leclere, Olivier Delcroix, Jean Rousset, et al.
Pathology
|
September 14, 2021
Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing
Amélie Bourhis, Charline Caumont, Isabelle Quintin-Roué, et al.
Scientific Reports
|
April 8, 2023
Prognostic value of pre-therapeutic FDG-PET radiomic analysis in gastro-esophageal junction cancer
Karim Amrane, Philippe Thuillier, David Bourhis, et al.
Cancers
|
April 2, 2020
External Validation of an MRI-Derived Radiomics Model to Predict Biochemical Recurrence after Surgery for High-Risk Prostate Cancer
Vincent Bourbonne, Georges Fournier, Martin Vallières, et al.
Rare Tumors
|
October 3, 2014
History of the rare cancer network and past research
René-Olivier Mirimanoff, Mahmut Ozsahin, Juliette Thariat, et al.
Cancer Medicine
|
February 6, 2020
First-line pembrolizumab for non-small cell lung cancer patients with PD-L1 ≥50% in a multicenter real-life cohort: The PEMBREIZH study
Karim Amrane, Margaux Geier, Romain Corre, et al.
Cancers
|
March 29, 2023
A Feasibility Study of Functional Lung Volume Preservation during Stereotactic Body Radiotherapy Guided by Gallium-<sup>68</sup> Perfusion PET/CT
François Lucia, Mohamed Hamya, Fanny Pinot, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 15, 2012
Clinical impact of 18F-choline PET/CT in patients with recurrent prostate cancer
Jan D Soyka, Marco A Muster, Daniel T Schmid, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 11, 2024
Diagnostic Performance of <sup>18</sup>F-FDG PET/CT According to Delay After Treatment to Detect Subclinical Recurrence of Head and Neck Squamous Cell Carcinoma
Camille Clement, Jean-Christophe Leclère, Clémentine Maheo, et al.
Page
of 15